.
MergerLinks Header Logo

New Deal


Announced

Completed

Pitango led a $108m Series C round in Patient21.

Financials

Edit Data
Transaction Value£86m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Private Equity

Health Care Services

healthcare platform

Friendly

Single Bidder

Completed

Germany

Cross Border

Minority

Venture Capital

Acquisition

Private

Synopsis

Edit

Pitango, a venture capital company, led a $108m Series C round in Patient21, a healthtech company, with participation from Bertelsmann Investments, Artian, Target Global, Piton Capital, PICO Venture Partners, Mario Kohle and Maria Raga. “Dentistry inherently requires in-person consultations for comprehensive diagnosis and treatment. The nature of dentistry involves visually inspecting oral health, utilizing diagnostic tools like x-rays and addressing emergencies promptly. These aspects are best served through onsite consultations to ensure the highest standards of care," Chris Muhr, Patient21 Co-Founder and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US